Nnamdi Etoh
@Rock Springs Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
WRBYWarby Parker Inc
| 0.77% | $23.5M 1.439M shares@ $16.34 avg price | Decreased -30.81% |
LFSTLifestance Health Group Inc
| 0.71% | $21.707M 3.101M shares@ $7.0 avg price | Decreased -35.76% |
OSCROscar Health Inc
| 0.7% | $21.452M 1.011M shares@ $21.21 avg price | Decreased -19.18% |
NVONovo-nordisk A S
| 0.52% | $15.717M 132,000 shares@ $119.07 avg price | Decreased -10.5% |
JNJJohnson & Johnson
| 0.43% | $12.965M 80,000 shares@ $162.06 avg price | Decreased -52.94% |
KRYSKrystal Biotech Inc
| 0.34% | $10.168M 55,861 shares@ $182.04 avg price | Decreased -47.08% |
NVAXNovavax Inc
| 0.27% | $8.21M 650,000 shares@ $12.63 avg price | Decreased -3.7% |
DVAXDynavax Technologies Corp
| 0.22% | $6.74M 605,013 shares@ $11.15 avg price | Decreased -53.19% |
PCRXPacira Biosciences Inc
| 0.2% | $6.02M 400,000 shares@ $15.05 avg price | Decreased -49.04% |
APLSApellis Pharmaceuticals Inc
| 0.08% | $2.307M 80,000 shares@ $28.84 avg price | Decreased -43.14% |